Treatable Intellectual Disability

3-Methylcrotonylglycinuria

DIAGNOSIS

Gene
MCC1 / MCC2 (AR)

Diagnostic Test
Urine Organic Acids, Acylcarnitine Profile

Stacks Image 333

SIGNS & SYMPTOMS

Neurological
White matter abnormalities (MRIscan)

Non-Neurological
Urine sweaty feet odor

Stacks Image 334

THERAPY

Treatment
Dietary Protein Restriction; Carnitine, Glycine, Biotin Supplements; Avoid Fasting; Sick Day Management

Level of Evidence
5

Clinical Practice
Standard of Care

Treatment Effect
Prevents metabolic decompensation



Stacks Image 335
3-Methylcrotonylglycinuria

3-Methylcrotonylglycinuria

Isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine catabolism. The phenotype is variable, ranging from neonatal onset with severe neurological involvement, to unspecific developmental delay and asymptomatic adults. Acute metabolic crisis follows a minor infection or introduction of a protein-rich diet. Symptoms include vomiting, opisthotonus, involuntary movements, seizures, coma and apnoea, and are often accompanied by severe hypoglycemia, ketoacidosis and mild hyperammonemia. The patients usually respond to intravenous fluids and cessation of protein feeding and are asymptomatic between acute episodes. (Source: Orphanet)

No information available from this source.

This disease is not (yet) listed on their website.